Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC1
|
ENSG00000131196.13 | nuclear factor of activated T cells 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_77159557_77160137 | NFATC1 | 475 | 0.855604 | -0.83 | 5.5e-03 | Click! |
chr18_77159340_77159496 | NFATC1 | 904 | 0.662874 | -0.77 | 1.4e-02 | Click! |
chr18_77165970_77166171 | NFATC1 | 5678 | 0.264296 | -0.71 | 3.1e-02 | Click! |
chr18_77160344_77160704 | NFATC1 | 132 | 0.972457 | -0.71 | 3.1e-02 | Click! |
chr18_77165463_77165878 | NFATC1 | 5278 | 0.268046 | -0.67 | 4.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr21_17960305_17960805 | 0.80 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr6_23004070_23004285 | 0.74 |
ENSG00000207394 |
. |
121138 |
0.07 |
chr19_34359259_34359976 | 0.73 |
ENSG00000240626 |
. |
58913 |
0.13 |
chr17_79317268_79317735 | 0.70 |
TMEM105 |
transmembrane protein 105 |
13027 |
0.13 |
chr12_116872831_116873001 | 0.70 |
ENSG00000264037 |
. |
6793 |
0.3 |
chr4_55096373_55096991 | 0.70 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
193 |
0.97 |
chr3_25469138_25469713 | 0.68 |
RARB |
retinoic acid receptor, beta |
329 |
0.93 |
chr3_98618999_98619299 | 0.64 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
866 |
0.54 |
chr6_97545575_97545734 | 0.62 |
KLHL32 |
kelch-like family member 32 |
33150 |
0.23 |
chr4_81189966_81190509 | 0.61 |
FGF5 |
fibroblast growth factor 5 |
2444 |
0.36 |
chr7_70201396_70202343 | 0.59 |
AUTS2 |
autism susceptibility candidate 2 |
7744 |
0.34 |
chr5_38846105_38846894 | 0.59 |
OSMR |
oncostatin M receptor |
398 |
0.91 |
chr4_114680063_114680214 | 0.57 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
2086 |
0.48 |
chr13_40174017_40174396 | 0.57 |
LHFP |
lipoma HMGIC fusion partner |
3102 |
0.29 |
chr11_8831505_8831934 | 0.54 |
ST5 |
suppression of tumorigenicity 5 |
477 |
0.76 |
chr20_19956550_19956867 | 0.54 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
41052 |
0.15 |
chr2_227049788_227050011 | 0.53 |
ENSG00000263363 |
. |
473610 |
0.01 |
chr22_45865037_45865472 | 0.52 |
RP1-102D24.5 |
|
20630 |
0.17 |
chrX_8836868_8837019 | 0.52 |
FAM9A |
family with sequence similarity 9, member A |
67519 |
0.13 |
chr5_142777353_142777556 | 0.51 |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
2963 |
0.39 |
chr8_72776934_72777085 | 0.51 |
MSC |
musculin |
20306 |
0.17 |
chr3_114404388_114404544 | 0.51 |
ENSG00000264623 |
. |
57906 |
0.14 |
chr13_76212170_76212445 | 0.51 |
LMO7 |
LIM domain 7 |
1848 |
0.28 |
chr2_218843405_218844030 | 0.51 |
TNS1 |
tensin 1 |
60 |
0.79 |
chr14_50987831_50988146 | 0.51 |
MAP4K5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
11202 |
0.18 |
chr5_95768411_95768678 | 0.51 |
PCSK1 |
proprotein convertase subtilisin/kexin type 1 |
440 |
0.89 |
chr4_81192022_81192173 | 0.51 |
FGF5 |
fibroblast growth factor 5 |
4304 |
0.29 |
chr8_89311514_89311910 | 0.50 |
RP11-586K2.1 |
|
27353 |
0.2 |
chr1_95388573_95389173 | 0.50 |
CNN3 |
calponin 3, acidic |
2464 |
0.27 |
chr12_59311038_59311457 | 0.49 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2080 |
0.36 |
chr20_30084575_30084759 | 0.49 |
HM13 |
histocompatibility (minor) 13 |
17564 |
0.11 |
chr1_98514742_98514981 | 0.49 |
ENSG00000225206 |
. |
3134 |
0.4 |
chr9_22446798_22447485 | 0.48 |
DMRTA1 |
DMRT-like family A1 |
301 |
0.95 |
chr6_35182117_35182910 | 0.48 |
SCUBE3 |
signal peptide, CUB domain, EGF-like 3 |
317 |
0.9 |
chr4_181748689_181748884 | 0.48 |
NA |
NA |
> 106 |
NA |
chr4_123719295_123719464 | 0.48 |
FGF2 |
fibroblast growth factor 2 (basic) |
28484 |
0.16 |
chr8_92612283_92612746 | 0.47 |
ENSG00000200151 |
. |
5321 |
0.33 |
chr9_117879769_117880175 | 0.47 |
TNC |
tenascin C |
506 |
0.85 |
chr12_109226312_109226796 | 0.47 |
ENSG00000207622 |
. |
4228 |
0.18 |
chr8_24366846_24366997 | 0.47 |
RP11-561E1.1 |
|
5180 |
0.24 |
chr4_176922498_176923243 | 0.46 |
GPM6A |
glycoprotein M6A |
613 |
0.78 |
chr5_54128157_54128308 | 0.46 |
ENSG00000221073 |
. |
20544 |
0.24 |
chr12_88812633_88812784 | 0.46 |
ENSG00000199245 |
. |
11511 |
0.3 |
chr16_62068318_62068835 | 0.46 |
CDH8 |
cadherin 8, type 2 |
462 |
0.9 |
chr9_79520622_79521003 | 0.45 |
PRUNE2 |
prune homolog 2 (Drosophila) |
189 |
0.97 |
chr10_128593931_128594173 | 0.45 |
DOCK1 |
dedicator of cytokinesis 1 |
74 |
0.98 |
chr20_39944817_39945241 | 0.45 |
ZHX3 |
zinc fingers and homeoboxes 3 |
797 |
0.64 |
chr10_116444886_116445037 | 0.45 |
ABLIM1 |
actin binding LIM protein 1 |
547 |
0.83 |
chr6_72075753_72076050 | 0.44 |
ENSG00000199094 |
. |
10833 |
0.2 |
chr6_150176715_150177267 | 0.44 |
RP11-350J20.12 |
|
3393 |
0.15 |
chr2_151340168_151340387 | 0.44 |
RND3 |
Rho family GTPase 3 |
1619 |
0.57 |
chr2_210288891_210289443 | 0.44 |
MAP2 |
microtubule-associated protein 2 |
385 |
0.93 |
chr2_176996093_176996244 | 0.44 |
HOXD8 |
homeobox D8 |
1083 |
0.26 |
chr8_13369656_13370025 | 0.43 |
DLC1 |
deleted in liver cancer 1 |
2434 |
0.32 |
chr4_157889287_157889693 | 0.43 |
PDGFC |
platelet derived growth factor C |
2565 |
0.32 |
chr9_129916828_129917272 | 0.43 |
ANGPTL2 |
angiopoietin-like 2 |
31888 |
0.16 |
chr19_56166514_56167932 | 0.43 |
U2AF2 |
U2 small nuclear RNA auxiliary factor 2 |
792 |
0.34 |
chr1_147717990_147718807 | 0.42 |
ENSG00000199879 |
. |
17353 |
0.18 |
chr16_64245174_64245639 | 0.42 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
848175 |
0.0 |
chr12_79257392_79257783 | 0.42 |
SYT1 |
synaptotagmin I |
186 |
0.97 |
chr8_17611273_17611424 | 0.42 |
MTUS1 |
microtubule associated tumor suppressor 1 |
2142 |
0.28 |
chr13_22053308_22053484 | 0.42 |
ZDHHC20 |
zinc finger, DHHC-type containing 20 |
19887 |
0.19 |
chr13_76211856_76212147 | 0.42 |
LMO7 |
LIM domain 7 |
1542 |
0.32 |
chr10_30471562_30471725 | 0.42 |
ENSG00000200887 |
. |
116959 |
0.06 |
chr11_97853691_97853842 | 0.42 |
ENSG00000216073 |
. |
69877 |
0.14 |
chr7_100771614_100771864 | 0.42 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
1360 |
0.28 |
chr18_46848436_46848639 | 0.42 |
DYM |
dymeclin |
46530 |
0.14 |
chr2_239696091_239696242 | 0.41 |
TWIST2 |
twist family bHLH transcription factor 2 |
60507 |
0.14 |
chr12_116819288_116819767 | 0.41 |
ENSG00000264037 |
. |
46596 |
0.17 |
chr14_56711281_56711464 | 0.41 |
PELI2 |
pellino E3 ubiquitin protein ligase family member 2 |
125545 |
0.06 |
chr10_77156249_77156959 | 0.41 |
ENSG00000237149 |
. |
4673 |
0.21 |
chr8_86350363_86351282 | 0.41 |
CA3 |
carbonic anhydrase III, muscle specific |
234 |
0.93 |
chr1_162602307_162602458 | 0.41 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
122 |
0.97 |
chr5_146887879_146888030 | 0.41 |
DPYSL3 |
dihydropyrimidinase-like 3 |
1665 |
0.51 |
chr8_93074610_93074813 | 0.41 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
480 |
0.89 |
chr5_81701799_81702115 | 0.41 |
ATP6AP1L |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
100791 |
0.08 |
chr18_54070935_54071139 | 0.41 |
TXNL1 |
thioredoxin-like 1 |
210685 |
0.02 |
chr1_174389053_174389221 | 0.40 |
GPR52 |
G protein-coupled receptor 52 |
28075 |
0.23 |
chr14_79745937_79746359 | 0.40 |
NRXN3 |
neurexin 3 |
101 |
0.98 |
chr4_186577993_186578477 | 0.40 |
SORBS2 |
sorbin and SH3 domain containing 2 |
112 |
0.97 |
chr10_17274225_17274484 | 0.40 |
VIM |
vimentin |
1746 |
0.26 |
chr5_39421239_39421390 | 0.40 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
3656 |
0.34 |
chr2_17721828_17722425 | 0.40 |
VSNL1 |
visinin-like 1 |
163 |
0.97 |
chr5_16916952_16917142 | 0.40 |
MYO10 |
myosin X |
411 |
0.87 |
chr14_89973651_89973935 | 0.40 |
FOXN3 |
forkhead box N3 |
13264 |
0.2 |
chr1_90321564_90321715 | 0.40 |
LRRC8D |
leucine rich repeat containing 8 family, member D |
9500 |
0.25 |
chr5_13986133_13986412 | 0.40 |
DNAH5 |
dynein, axonemal, heavy chain 5 |
41620 |
0.21 |
chr4_88939495_88939878 | 0.40 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
10866 |
0.19 |
chr9_112555819_112555970 | 0.39 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
13125 |
0.16 |
chr9_111861305_111861456 | 0.39 |
TMEM245 |
transmembrane protein 245 |
11807 |
0.18 |
chr22_46453843_46454104 | 0.39 |
RP6-109B7.3 |
|
3178 |
0.13 |
chr10_124254663_124255115 | 0.39 |
HTRA1 |
HtrA serine peptidase 1 |
11318 |
0.2 |
chr9_75771174_75771814 | 0.39 |
ANXA1 |
annexin A1 |
1076 |
0.66 |
chr11_88242003_88242805 | 0.39 |
GRM5-AS1 |
GRM5 antisense RNA 1 |
2512 |
0.42 |
chr1_242310080_242310365 | 0.39 |
RP11-561I11.4 |
|
594 |
0.75 |
chr13_24807615_24808021 | 0.39 |
SPATA13 |
spermatogenesis associated 13 |
18014 |
0.17 |
chr5_169406944_169407149 | 0.39 |
FAM196B |
family with sequence similarity 196, member B |
698 |
0.77 |
chr6_131291045_131291463 | 0.38 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
369 |
0.93 |
chr12_13326265_13326502 | 0.38 |
EMP1 |
epithelial membrane protein 1 |
23267 |
0.21 |
chr17_15686261_15686502 | 0.38 |
ENSG00000251829 |
. |
726 |
0.64 |
chr2_50876595_50876746 | 0.38 |
ENSG00000216191 |
. |
46730 |
0.19 |
chr15_95847511_95847662 | 0.38 |
ENSG00000222076 |
. |
441447 |
0.01 |
chr9_686616_686767 | 0.38 |
RP11-130C19.3 |
|
1136 |
0.55 |
chr10_35098017_35098428 | 0.38 |
PARD3 |
par-3 family cell polarity regulator |
6027 |
0.24 |
chr6_3825964_3826270 | 0.38 |
RP11-420L9.4 |
|
6050 |
0.22 |
chr2_221969079_221969387 | 0.38 |
EPHA4 |
EPH receptor A4 |
398047 |
0.01 |
chrX_25022630_25023098 | 0.38 |
ARX |
aristaless related homeobox |
11201 |
0.27 |
chr7_105705584_105705867 | 0.38 |
SYPL1 |
synaptophysin-like 1 |
32583 |
0.2 |
chr6_28641788_28642196 | 0.37 |
ENSG00000272278 |
. |
25950 |
0.18 |
chr8_77594044_77594273 | 0.37 |
ZFHX4 |
zinc finger homeobox 4 |
604 |
0.67 |
chr12_88973184_88973445 | 0.37 |
KITLG |
KIT ligand |
924 |
0.59 |
chr14_91585821_91585989 | 0.37 |
C14orf159 |
chromosome 14 open reading frame 159 |
4861 |
0.17 |
chr12_88969721_88970003 | 0.37 |
KITLG |
KIT ligand |
4376 |
0.27 |
chr12_66222342_66222753 | 0.37 |
HMGA2 |
high mobility group AT-hook 2 |
3644 |
0.26 |
chr8_125212210_125212404 | 0.36 |
FER1L6-AS2 |
FER1L6 antisense RNA 2 |
28544 |
0.2 |
chr12_65997737_65997888 | 0.36 |
HMGA2 |
high mobility group AT-hook 2 |
220099 |
0.02 |
chr18_66465448_66465631 | 0.36 |
CCDC102B |
coiled-coil domain containing 102B |
113 |
0.97 |
chr3_157335850_157336001 | 0.36 |
C3orf55 |
chromosome 3 open reading frame 55 |
74692 |
0.11 |
chr1_185688405_185688780 | 0.36 |
HMCN1 |
hemicentin 1 |
15091 |
0.26 |
chr13_29132587_29132851 | 0.36 |
FLT1 |
fms-related tyrosine kinase 1 |
63454 |
0.13 |
chr19_47735595_47736220 | 0.36 |
BBC3 |
BCL2 binding component 3 |
116 |
0.95 |
chr7_116168289_116168733 | 0.36 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
2164 |
0.26 |
chr2_28183635_28183870 | 0.36 |
ENSG00000265321 |
. |
35482 |
0.16 |
chr10_15721874_15722025 | 0.36 |
ITGA8 |
integrin, alpha 8 |
40175 |
0.21 |
chr1_65005729_65006114 | 0.36 |
ENSG00000264470 |
. |
39609 |
0.19 |
chrX_78003533_78003765 | 0.36 |
LPAR4 |
lysophosphatidic acid receptor 4 |
421 |
0.91 |
chr6_27512445_27512692 | 0.36 |
ENSG00000206671 |
. |
51623 |
0.12 |
chr10_95802546_95802812 | 0.35 |
ENSG00000252895 |
. |
4203 |
0.22 |
chr13_39343461_39343612 | 0.35 |
ENSG00000252795 |
. |
10025 |
0.21 |
chr4_54948203_54948354 | 0.35 |
CHIC2 |
cysteine-rich hydrophobic domain 2 |
17421 |
0.14 |
chr17_43047514_43047990 | 0.35 |
C1QL1 |
complement component 1, q subcomponent-like 1 |
2313 |
0.2 |
chr2_169675855_169676058 | 0.35 |
NOSTRIN |
nitric oxide synthase trafficking |
8112 |
0.22 |
chr10_70752333_70752623 | 0.35 |
KIAA1279 |
KIAA1279 |
3991 |
0.2 |
chr3_156570645_156570796 | 0.35 |
LEKR1 |
leucine, glutamate and lysine rich 1 |
26572 |
0.24 |
chr12_18536570_18536736 | 0.35 |
PIK3C2G |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
101675 |
0.08 |
chr5_111084206_111084519 | 0.35 |
NREP |
neuronal regeneration related protein |
7586 |
0.21 |
chr8_69672880_69673031 | 0.35 |
ENSG00000239184 |
. |
65077 |
0.15 |
chr16_11444934_11445085 | 0.35 |
RP11-485G7.6 |
|
1831 |
0.18 |
chr2_63276750_63277690 | 0.35 |
OTX1 |
orthodenticle homeobox 1 |
28 |
0.97 |
chr6_158182224_158182417 | 0.35 |
SNX9 |
sorting nexin 9 |
61976 |
0.12 |
chrX_71905796_71905947 | 0.34 |
PHKA1-AS1 |
PHKA1 antisense RNA 1 |
2929 |
0.24 |
chr7_27218725_27218915 | 0.34 |
RP1-170O19.20 |
Uncharacterized protein |
812 |
0.27 |
chr10_74562802_74562983 | 0.34 |
RP11-354E23.5 |
|
36574 |
0.15 |
chr5_138206284_138206563 | 0.34 |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
3304 |
0.25 |
chr13_76259054_76259476 | 0.34 |
LMO7 |
LIM domain 7 |
48806 |
0.13 |
chr5_121412020_121412268 | 0.34 |
LOX |
lysyl oxidase |
1836 |
0.4 |
chr5_141980216_141980760 | 0.34 |
AC005592.2 |
|
19075 |
0.18 |
chr18_10058041_10058330 | 0.34 |
ENSG00000263630 |
. |
52991 |
0.15 |
chr2_19557319_19557513 | 0.34 |
OSR1 |
odd-skipped related transciption factor 1 |
739 |
0.74 |
chr3_100515408_100515559 | 0.34 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
8205 |
0.28 |
chr2_38265076_38265999 | 0.34 |
RMDN2-AS1 |
RMDN2 antisense RNA 1 |
2053 |
0.33 |
chr1_178207524_178207696 | 0.34 |
RASAL2 |
RAS protein activator like 2 |
102996 |
0.08 |
chr4_14864468_14865022 | 0.34 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
139553 |
0.05 |
chr14_90280432_90280702 | 0.34 |
ENSG00000200312 |
. |
101712 |
0.07 |
chr7_121513797_121514084 | 0.34 |
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
525 |
0.87 |
chr10_44788968_44789259 | 0.34 |
RP11-20J15.3 |
|
44 |
0.99 |
chr5_39102785_39103048 | 0.34 |
AC008964.1 |
|
2442 |
0.36 |
chr1_218672222_218672541 | 0.34 |
C1orf143 |
chromosome 1 open reading frame 143 |
11057 |
0.26 |
chr10_104536223_104536534 | 0.34 |
WBP1L |
WW domain binding protein 1-like |
372 |
0.83 |
chr6_25312716_25313084 | 0.34 |
ENSG00000207286 |
. |
25139 |
0.15 |
chr4_95466530_95466732 | 0.34 |
PDLIM5 |
PDZ and LIM domain 5 |
21755 |
0.28 |
chr5_77189257_77189408 | 0.33 |
TBCA |
tubulin folding cofactor A |
24728 |
0.26 |
chr11_78021681_78021861 | 0.33 |
RP11-452H21.1 |
|
14033 |
0.18 |
chr1_234669487_234669677 | 0.33 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
54733 |
0.11 |
chr15_36623727_36623943 | 0.33 |
C15orf41 |
chromosome 15 open reading frame 41 |
247977 |
0.02 |
chr12_53443889_53444561 | 0.33 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
255 |
0.86 |
chr1_185687957_185688174 | 0.33 |
HMCN1 |
hemicentin 1 |
15618 |
0.26 |
chr7_15724696_15724847 | 0.33 |
MEOX2 |
mesenchyme homeobox 2 |
1666 |
0.46 |
chr1_107684993_107685186 | 0.33 |
NTNG1 |
netrin G1 |
1428 |
0.58 |
chr7_104621470_104621621 | 0.33 |
ENSG00000251911 |
. |
9811 |
0.17 |
chr19_52452059_52452669 | 0.33 |
HCCAT3 |
hepatocellular carcinoma associated transcript 3 (non-protein coding) |
23 |
0.96 |
chr14_69419495_69419882 | 0.33 |
ACTN1 |
actinin, alpha 1 |
5423 |
0.25 |
chr12_78336681_78336916 | 0.33 |
NAV3 |
neuron navigator 3 |
23258 |
0.28 |
chr6_97386906_97387057 | 0.33 |
KLHL32 |
kelch-like family member 32 |
14229 |
0.2 |
chr6_156336017_156336168 | 0.33 |
ENSG00000221456 |
. |
68161 |
0.14 |
chr8_67454441_67454873 | 0.33 |
ENSG00000206949 |
. |
41111 |
0.13 |
chr7_142926484_142926635 | 0.33 |
AC073342.1 |
HCG2002387; Uncharacterized protein |
7199 |
0.12 |
chr6_53357715_53357921 | 0.33 |
RP1-27K12.4 |
|
10165 |
0.18 |
chr14_52519313_52519627 | 0.33 |
NID2 |
nidogen 2 (osteonidogen) |
13800 |
0.2 |
chr13_20175736_20176974 | 0.32 |
MPHOSPH8 |
M-phase phosphoprotein 8 |
31433 |
0.18 |
chr12_104233643_104233794 | 0.32 |
NT5DC3 |
5'-nucleotidase domain containing 3 |
1257 |
0.32 |
chr11_128778623_128778851 | 0.32 |
KCNJ5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
2342 |
0.24 |
chr5_125460794_125460955 | 0.32 |
ENSG00000265637 |
. |
71654 |
0.13 |
chr8_37310276_37310698 | 0.32 |
RP11-150O12.6 |
|
64052 |
0.13 |
chr7_25895792_25896027 | 0.32 |
ENSG00000199085 |
. |
93697 |
0.09 |
chr8_85513931_85514082 | 0.32 |
ENSG00000206701 |
. |
64094 |
0.14 |
chr5_121477747_121477957 | 0.32 |
ZNF474 |
zinc finger protein 474 |
12591 |
0.17 |
chr3_98619314_98619465 | 0.32 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
626 |
0.66 |
chr14_89956186_89956636 | 0.32 |
FOXN3 |
forkhead box N3 |
3984 |
0.26 |
chr13_76213551_76213793 | 0.32 |
LMO7 |
LIM domain 7 |
3213 |
0.22 |
chr18_10454899_10455524 | 0.32 |
APCDD1 |
adenomatosis polyposis coli down-regulated 1 |
232 |
0.95 |
chr7_41734837_41734988 | 0.32 |
INHBA-AS1 |
INHBA antisense RNA 1 |
1366 |
0.45 |
chr18_12656814_12657797 | 0.32 |
SPIRE1 |
spire-type actin nucleation factor 1 |
570 |
0.5 |
chr13_24626733_24626884 | 0.32 |
SPATA13 |
spermatogenesis associated 13 |
72864 |
0.1 |
chr19_54483356_54483962 | 0.32 |
ENSG00000215998 |
. |
1902 |
0.19 |
chr4_177484526_177484677 | 0.31 |
RP11-313E19.2 |
|
106171 |
0.07 |
chr15_61327175_61327382 | 0.31 |
RP11-39M21.1 |
|
146170 |
0.04 |
chr22_40894900_40895196 | 0.31 |
RP4-591N18.2 |
|
22756 |
0.15 |
chr2_36585229_36585663 | 0.31 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
1832 |
0.5 |
chr18_73688861_73689088 | 0.31 |
RP11-94B19.4 |
Uncharacterized protein |
282147 |
0.01 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.4 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.1 | GO:0072338 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.2 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.1 | 0.2 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 1.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0060601 | prostatic bud formation(GO:0060513) lateral sprouting from an epithelium(GO:0060601) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.2 | GO:0060343 | trabecula formation(GO:0060343) heart trabecula formation(GO:0060347) trabecula morphogenesis(GO:0061383) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.3 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.2 | GO:0021940 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.1 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 2.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.4 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.4 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.2 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0030917 | midbrain-hindbrain boundary morphogenesis(GO:0021555) midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.0 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.3 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.6 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0009415 | response to water(GO:0009415) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.2 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 0.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.0 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.4 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 2.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.4 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 1.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |